Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02898350 · ClinicalTrials.gov registry record · NA
Surgical Scar Treatment With the Pulsed Dye Laser in Combination With a CO2 Laser
A NA study of Scars, sponsored by Syneron Medical.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT02898350: Completed NA study of Scars, sponsored by Syneron Medical.
NCT02898350 is a NA study of Scars that has completed, run by Syneron Medical. The registered enrollment target is 25 participants, below the 231-participant average among 4 other Scars trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02898350, a NA study of Scars, has completed, sponsored by Syneron Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective, randomized, split lesion treatment with 4 study Arms to evaluate safety and efficacy of combined treatment for minimizing of surgical scars, including post Moh's surgery.
Primary Outcome
Blinded review of 7-point Global Evaluation Response (GER) scale
Conditions Studied
Interventions
- DEVICE Pulsed dye laser treatment
- DEVICE CO2 laser treatment
- DEVICE Combined PDL and CO2 laser treatment
- DEVICE Split PDL and CO2 Laser treatment
Study Locations (2)
Colorado
- AboutSkin, Dermatology and Derm Surgery PC - Englewood
New York
- Laser & Skin Surgery Center of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02898350 record still lists
NCT02898350 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 231-participant average among 4 other Scars trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Scars appearing as the primary indexed condition, and to 4 interventions - of which Pulsed dye laser treatment is the first listed.
NCT02898350 reports a single indexed study location in Colorado, New York.
Frequently Asked Questions
What is clinical trial NCT02898350 about?
NCT02898350 is a clinical study titled "Surgical Scar Treatment With the Pulsed Dye Laser in Combination With a CO2 Laser". Prospective, randomized, split lesion treatment with 4 study Arms to evaluate safety and efficacy of combined treatment for minimizing of surgical scars, including post Moh's surgery.
What is the current status of trial NCT02898350?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2013-02. Estimated completion is 2016-09.
What conditions does trial NCT02898350 study?
This clinical trial studies the following conditions: Scars.
What interventions are being tested in trial NCT02898350?
The interventions under investigation include: Pulsed dye laser treatment (DEVICE), CO2 laser treatment (DEVICE), Combined PDL and CO2 laser treatment (DEVICE), Split PDL and CO2 Laser treatment (DEVICE).
Who is sponsoring clinical trial NCT02898350?
This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02898350 being conducted?
This trial has 2 study locations across Colorado, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scars
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia